On November 23rd, 2022, Prof. Apichat Asavamongkolkul, Dean of the Faculty of Medicine Siriraj Hospital, Mahidol University, in the capacity of Vice President of the Prince Mahidol Award Foundation, Clin. Prof. Supat Vanichakarn, Secretary General of the Prince Mahidol Award Foundation under the Royal Patronage, Mr. Tanee Sangrat, Spokesman of the Ministry of Foreign Affairs, as the representative of Chairman of the Sub-Committee on Public Relations of the Prince Mahidol Award Foundation, and Prof. Vicharn Panich, Chairman of the International Award Committee of the Prince Mahidol Award Foundation, held a joint press conference to announce the 31st Prince Mahidol Award for 2022 at the Prince Mahidol Memorial Room, 2nd Floor, Syamindra Building, Faculty of Medicine Siriraj Hospital, Mahidol University.
The Prince Mahidol Award 2022 in the field of Medicine is awarded to Prof. Ralph A. DeFronzo, MD., from the USA.
The Prince Mahidol Award 2022 in the field of Public Health is awarded to Dr. Douglas R. Lowy, MD., and Dr. John T. Schiller, Ph.D., (both from the USA), and Prof. Ian H. Frazer, MB.ChB, M.D., from the UK/Australia.
There were 88 nominations from 34 countries. The Scientific Advisory Committee carefully screened all candidates from the year 2019 – 2022 and subsequently submitted a short list of candidates to the International Award Committee who made a recommendation to the Board of Trustees. H.R.H. Princess Maha Chakri Sirindhorn presided over the meeting of the Board of Trustees held on October 31st, 2022, during which the final decision on the Prince Mahidol Award 2022 was made.
Prince Mahidol Award Laureate 2022
in the Field of Medicine
Ralph A. DeFronzo, MD.
Professor of Medicine, Diabetes division,
University of Texas Health Science center at San Antonio, Texas, USA.
In the Field of Public Health
Douglas R. Lowy, M.D.
Deputy Director
National Cancer Institute, National Institutes of Health, Bethesda,
USA
John T. Schiller, Ph.D.
NIH Distinguished Investigator
Deputy Chief, Laboratory of Cellular Oncology
National Cancer Institute, National Institutes of Health, Bethesda,
USA
Ian Frazer, M.D.
Emeritus professor, University of Queensland, Brisbane, Australia
Australia / UK